a clinical-stage biopharmaceutical company
Industry Biotechnology
A.I.dvisor indicates that over the last year, NERV has been loosely correlated with ASPHF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if NERV jumps, then ASPHF could also see price increases.
Ticker / NAME | Correlation To NERV | 1D Price Change % | ||
---|---|---|---|---|
NERV | 100% | +4.57% | ||
ASPHF - NERV | 44% Loosely correlated | N/A | ||
NRXP - NERV | 24% Poorly correlated | +36.67% | ||
BZYR - NERV | 22% Poorly correlated | +16.74% | ||
BPTH - NERV | 22% Poorly correlated | +3.60% | ||
RVMD - NERV | 21% Poorly correlated | +1.01% | ||
More |